New $11 million winter vaccine communication campaign and availability of antivirals

22 June 2022 - The Australian Government today launched an $11 million six-week campaign to encourage people to get vaccinated for ...

Read more →

HIRA reviews reimbursing antidiabetic combo therapies

15 June 2022 - HIRA has been analysing how new reimbursements for anti-diabetic combination therapies mixing oral SGLT-2 and DPP-4 ...

Read more →

PHARMAC's latest breast cancer drug funding 'way short' - advocate

16 June 2022 - On Wednesday PHARMAC announced $190 million to fund cancer treatments and other medicines. ...

Read more →

NHS lands breakthrough in global battle against superbugs

15 June 2022 - The NHS is set to roll out two ‘superbug’ busting drugs through a world first, pioneering ...

Read more →

New PHARMAC funded cancer drugs already 'old and cheap', patient advocate Malcolm Mulholland says

16 June 2022 - New cancer drugs that will now be funded by the Government drug buying agency are already ...

Read more →

EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases

15 June 2022 - Today marks the publication of the EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases.  ...

Read more →

PHARMAC widens access to safe sex drug after 'overwhelming support'

15 June 2022 - PHARMAC is overhauling its criteria for prescriptions to an effective safe sex drug common to gay men. ...

Read more →

Calls for 'blockbuster' osteoporosis drug to be made widely available

14 June 2022 - Experts want to see a new "blockbuster" drug made accessible for more patients suffering from osteoporosis. ...

Read more →

PHARMAC announces first round of medicine funding decisions following $191 million pharmaceutical budget increase

15 June 2022 - PHARMAC today announces the first round of changes to medicines funding following its $191 million pharmaceutical ...

Read more →

PHARMAC seeks views on access criteria for COVID-19 treatments

14 June 2022 - PHARMAC is seeking feedback on access criteria for two new COVID-19 treatments – tixagevimab with cilgavimab ...

Read more →

The days of the independent republic of PHARMAC are far from over

9 June 2022 - When he announced the government’s response to the recent independent review of PHARMAC Health Minister Andrew Little ...

Read more →

TLV reconsiders subsidy of cyclin-dependent kinase 4/6 inhibitor Verzenios

8 June 2022 - Since April 2022, Verzenios has had market approval for the treatment of adult patients with early breast ...

Read more →

Irish parents ‘breaking down and crying’ as children denied life changing cystic fibrosis medication

8 June 2022 - Sarah O’Keeffe found out that her son would not be getting the medication that would improve his ...

Read more →

Response to engagement on proposals for the Innovative Medicines Fund

7 June 2022 - NHS England and NICE asked for comments on our proposals for the Innovative Medicines Fund.  ...

Read more →

Patients to have earlier access to cutting edge treatments on NHS

7 June 2022 - The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund ...

Read more →